Ascendis Pharma A (ASND) Receivables Refunds: 2014-2025
Historic Receivables Refunds for Ascendis Pharma A (ASND) over the last 10 years, with Sep 2025 value amounting to $3.4 million.
- Ascendis Pharma A's Receivables Refunds rose 56.66% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 56.66%. This contributed to the annual value of $1.9 million for FY2024, which is 122.64% up from last year.
- Per Ascendis Pharma A's latest filing, its Receivables Refunds stood at $3.4 million for Q3 2025, which was up 10.75% from $3.1 million recorded in Q2 2025.
- In the past 5 years, Ascendis Pharma A's Receivables Refunds ranged from a high of $3.4 million in Q3 2025 and a low of $806,081 during Q1 2024.
- Over the past 3 years, Ascendis Pharma A's median Receivables Refunds value was $1.8 million (recorded in 2023), while the average stood at $1.9 million.
- Data for Ascendis Pharma A's Receivables Refunds shows a peak YoY increase of 119.81% (in 2024) and a maximum YoY decrease of 29.42% (in 2024) over the last 5 years.
- Over the past 5 years, Ascendis Pharma A's Receivables Refunds (Quarterly) stood at $1.0 million in 2021, then dropped by 11.81% to $900,878 in 2022, then fell by 4.22% to $862,904 in 2023, then soared by 119.81% to $1.9 million in 2024, then skyrocketed by 56.66% to $3.4 million in 2025.
- Its Receivables Refunds was $3.4 million in Q3 2025, compared to $3.1 million in Q2 2025 and $1.7 million in Q1 2025.